Drugs / VM206Ad
last change Oct 2013 re-read 3 minutes ago

VM206Ad

Developed for
breast cancer
Investigated by
Reyon Pharmaceutical Co., Ltd.

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01895491 Mar 2011 → Jul 2013 breast cancer Reyon Pharmaceutical Co., Ltd. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as VM206Ad ClinicalTrials.gov intervention name — accepted as the source's own label NCT01895491 ↗
Route Intramuscular “injected into the brachial muscle” NCT01895491 ↗